PAMORELIN SUSP INY 11 25MG OFFENBACH P NETO Monitoreo cardiovascular

Description

Monitoreo cardiovascular

Administrar mediante infusión intravenosa cada 4 semanas

PRINCIPIO ACTIVO: CILOSTAZOL

PRINCIPIO ACTIVO: ERITROMICINA (OFTALMICA)

PAMORELIN SUSP INY 11 25MG OFFENBACH P NETO Monitoreo cardiovascular

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy